Jazz Pharmaceuticals Director Laura Hamill Files Form 144 to Sell $857K in Common Shares
Jazz Pharmaceuticals plc
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 144 Proposed Sale Notice Issuer: Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Insider: Laura Hamill (Director) Shares to Sell: 3,507 Common Shares Aggregate Market Value: $857,602.00 (~$244.54/share) Origin of Shares: Restricted Stock Vesting (08/28/2026) Approximate Sale Date: 08/31/2026 Broker: E*TRADE Financial Corporation
Comprehensive Analysis
Form 144 Analysis: Jazz Pharmaceuticals plc
- Insider: Laura Hamill, Director
- Planned Transaction: Notice of proposed sale of 3,507 shares of Common Stock under Rule 144.
- Estimated Total Value: $857,602.00 (implied price of ~$244.54 per share).
- Acquisition Details: The shares were recently acquired on August 28, 2026, via restricted stock vesting as part of director equity compensation.
- Market Impact & Significance: Low. The proposed transaction represents a routine monetization of vested equity compensation and is immaterial relative to the issuer's total outstanding share count of approximately 64.9 million shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.